Abstract L06 shows the efficacy of Emapalumab, an IFN-γ mAb, when given to 9 systemic JIA pts who developed macrophage activation syndrome. Highly effective showing ability to lower steroid use #ACR19 https://t.co/hduMrzWt72
Links:
Interferon-gamma (IFN-γ) Neutralization with Emapalumab and Time to Response in…
http://bit.ly/2Kzavs4
Nov-19-2019
